Home > Resources > Whitepapers > Global Awareness to Alzheimer's Disease and Dementia

Global Awareness to Alzheimer's Disease and Dementia

June 24, 2019

The global economic impact growth of IoT by the end of 2025 is estimated to be around $12.5 trillion with more than 100 billion connected IoT devices. Developments worldwide expand the market for diagnosing, treating and monitoring neurodegenerative disorders. Developed and developing national markets hold high potential til 2025. IoT is expected to offer advanced connectivity of devices, systems, and services that goes beyond machine-to-machine (M2M) communications and covers a variety of protocols, domains, and applications. The interconnection of these embedded devices (including smart objects), is expected to usher in automation in nearly all fields, while also enabling advanced applications like a smart grid, and expanding to the areas such as smart cities.

I'm For Real

Enter your details once to access all our information and resources

 

Spotlight

Camomile Healthcare

Camomile Healthcare is a boutique healthcare organization focused on emerging markets. We operate in two key verticals viz. Our team consists of senior industry professionals who have been involved with creating some of the largest healthcare businesses in India and the region. Some of our recent works include healthcare domain side advisory and due diligence for a US$200 Bn investment firm for acquisition of one of the largest Hospital chains in India and Medical Planning and Operational Strategy for CMC Vellore, a top 5 Academic Medical Institution in Asia for their upcoming 1500 bed facility spread over 1.5 million sq. ft.

OTHER WHITEPAPERS
news image

Shielding Healthcare from Cyberthreats

whitePaper | November 14, 2019

The sheer magnitude of hacker attention isn’t the only concern for healthcare security professionals. The job of securing the healthcare technology ecosystem is made infinitely more complicated by several factors that are unique to healthcare.

Read More
news image

A New Horizon for Digital Health Technologies

whitePaper | December 9, 2022

The paradigm shift in the digital clinical trial enterprise is here from an increase in trial adoption to enterprise scale.

Read More
news image

Addressing Total Cost of Care Across the Specialty Population

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

Read More
news image

Improving and Strengthening Employer-Sponsored Insurance

whitePaper | October 22, 2022

Under the leadership of former Senate Majority Leaders Tom Daschle and Bill Frist, M.D., BPC’s Health Program develops bipartisan policy recommendations that will improve health care quality, lower costs, and enhance coverage.

Read More
news image

The Rise of Hybrid Clinical Trials

whitePaper | September 21, 2022

Prior to 2020, the answer was likely not very much. Although decentralized trials (DCT) existed prior to the pandemic, COVID-19 undoubtedly had a large impact on the rapid adoption of DCT technologies.

Read More
news image

As patient care channels become more fragmented, communications & coordination can become integrated

whitePaper | June 30, 2022

A platform approach to clinical communications keeps clinicians connected and patient data more secure

Read More

Shielding Healthcare from Cyberthreats

whitePaper | November 14, 2019

The sheer magnitude of hacker attention isn’t the only concern for healthcare security professionals. The job of securing the healthcare technology ecosystem is made infinitely more complicated by several factors that are unique to healthcare.

Read More

A New Horizon for Digital Health Technologies

whitePaper | December 9, 2022

The paradigm shift in the digital clinical trial enterprise is here from an increase in trial adoption to enterprise scale.

Read More

Addressing Total Cost of Care Across the Specialty Population

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

Read More

Improving and Strengthening Employer-Sponsored Insurance

whitePaper | October 22, 2022

Under the leadership of former Senate Majority Leaders Tom Daschle and Bill Frist, M.D., BPC’s Health Program develops bipartisan policy recommendations that will improve health care quality, lower costs, and enhance coverage.

Read More

The Rise of Hybrid Clinical Trials

whitePaper | September 21, 2022

Prior to 2020, the answer was likely not very much. Although decentralized trials (DCT) existed prior to the pandemic, COVID-19 undoubtedly had a large impact on the rapid adoption of DCT technologies.

Read More

As patient care channels become more fragmented, communications & coordination can become integrated

whitePaper | June 30, 2022

A platform approach to clinical communications keeps clinicians connected and patient data more secure

Read More
More Whitepapers

Spotlight

Camomile Healthcare

Camomile Healthcare is a boutique healthcare organization focused on emerging markets. We operate in two key verticals viz. Our team consists of senior industry professionals who have been involved with creating some of the largest healthcare businesses in India and the region. Some of our recent works include healthcare domain side advisory and due diligence for a US$200 Bn investment firm for acquisition of one of the largest Hospital chains in India and Medical Planning and Operational Strategy for CMC Vellore, a top 5 Academic Medical Institution in Asia for their upcoming 1500 bed facility spread over 1.5 million sq. ft.

Events

Innovation for Health 2023

Conference